Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06915454

High-Resolution PET-CT Imaging for Surgical Margin Visualization

Led by Vanderbilt-Ingram Cancer Center · Updated on 2026-05-08

50

Participants Needed

1

Research Sites

95 weeks

Total Duration

On this page

Sponsors

V

Vanderbilt-Ingram Cancer Center

Lead Sponsor

V

Vanderbilt University Medical Center

Collaborating Sponsor

AI-Summary

What this Trial Is About

Imaging will be exploratory and be used intraoperatively. There have been no discovered risks associated with the device to be used in this study, and none are anticipated given the diagnostic and non-invasive, 'ex vivo' nature of device use. Of note, the surgical resection will proceed as per standard of care and will not be affected by the research protocol. Potential Benefit: Imaging intra-operatively will ensure surgeons to identify at risk resection margins. Time Commitment: There are no additional visits that will be asked of you to partake in this study. Drug is FDA approved and Exposure to Radiation is minimal.

CONDITIONS

Official Title

High-Resolution PET-CT Imaging for Surgical Margin Visualization

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Biopsy confirmed diagnosis of any solid malignancy
  • Any T stage and subsite scheduled for definitive en bloc surgical resection, including recurrent or new primary disease
  • Planned standard of care oncologic surgery with curative intent
  • Male or female patients age 65 18 years
  • Life expectancy of more than 12 weeks
  • Karnofsky performance status of at least 70% or ECOG/Zubrod level 1
  • Acceptable glucose status (<200 mg/dL) on day of surgery prior to 18F-FDG injection
Not Eligible

You will not qualify if you...

  • General or local contraindications for resective surgery
  • Women who are pregnant or breast-feeding
  • Blood glucose level over 200 mg/dL prior to 18F-FDG infusion
  • Participation in other clinical trials or research with radiation exposure over 1 mSv in the past year, unless deemed safe by Principal Investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Vanderbilt University Medical Center

Nashville, Tennessee, United States, 37232

Actively Recruiting

Loading map...

Research Team

N

Nicole Jones

CONTACT

K

Kyrionna Golliday

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here